SEC Form 4 · accession 0001179022-19-000024
GALECTIN THERAPEUTICS INC · GALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gilbert F Amelio
Director
Period of report
Jan 30, 2019
Accepted (ET)
Feb 4, 2019 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001133416
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 30, 2019 | S | 16,953 | $5.00 | D | 167,661 | D | |
| Common Stock | Jan 31, 2019 | S | 13,047 | $5.00 | D | 154,614 | D |
Table II — derivative securities
No Table II lines on this filing.